CO-LOCATED EVENTS
NextPrevious

Session

Case Study

Monday, September 23

09:45 AM - 10:15 AM

Live in Berlin

Less Details

Join us for an enlightening presentation on the digital transformation of supply chain management, where we explore key innovations shaping the industry. Discover how automation, process mining, and digital workflow management are revolutionizing traditional practices, enhancing efficiency, and driving productivity. Learn how AI solutions, low code systems, and electronic data exchange are empowering enterprises to navigate complex challenges with agility and precision. Be inspired by real-world case studies and insights into agile leadership, as we navigate the path towards a more efficient, resilient, and digitally-driven supply chain landscape.

In this session, you will learn

  • How to install a digital roadmap for better exchange with suppliers
  • How to find solutions for better supplier management with the help of digital tools (AI)
  • How to develop strategies to strengthen the supply chain
  • How to decrease risks and obstacles 

Speaker

Johannes Carteus

Head of Global Quality for Suppliers & Incoming Materials, GSK Vaccines

Johannes Carteus is Head Global Quality for Suppliers & Incoming Materials at GSK. In his work he is leading on the Global Quality organization and managing suppliers and incoming materials. Also, he is responsible for the definition and implementationof global processes, policies and strategies through the entire GSK Vaccines manufacturing network. He has founded knowledge in the fields of Supplier Quality Assurance, Incoming Material Management and Risk Management.

Company

GSK Vaccines

GSK is a fully focused biopharma company. We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics, genomics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We focus on four therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.

NextPrevious